RESUMO
Monoclonal gammopathy of renal significance (MGRS) regroups renal disorders caused by a monoclonal immunoglobulin without overt hematological malignancy. MGRS includes tubular disorders, glomerular disorders with organized deposits, and glomerular disorders with non-organized deposits, such as proliferative glomerulonephritis with monoclonal IgG deposits. Since glomerular involvement related to monotypic IgA deposits is poorly described we performed retrospective analysis and defined clinico-biological characteristics, renal pathology, and outcome in 19 referred patients. This analysis allowed distinction between 2 types of glomerulopathies, α-heavy chain deposition disease (5 patients) and glomerulonephritis with monotypic IgA deposits (14 patients) suggestive of IgA-proliferative glomerulonephritis with monoclonal immunoglobulin deposits in 12 cases. Clinicopathologic characteristics of α-heavy chain deposition disease resemble those of the γ-heavy chain disease, except for a higher frequency of extra-capillary proliferation and extra-renal involvement. IgA-proliferative glomerulonephritis with monoclonal immunoglobulin deposits should be differentiated from diseases with polytypic IgA deposits, given distinct clinical, histological, and pathophysiological features. Similarly to IgG-proliferative glomerulonephritis with monoclonal immunoglobulin deposits, overt hematological malignancy was infrequent, but sensitive serum and bone marrow studies revealed a subtle plasma cell proliferation in most patients with IgA-proliferative glomerulonephritis with monoclonal immunoglobulin deposits. Anti-myeloma agents appeared to favorably influence renal prognosis. Thus, potential progression towards symptomatic IgA multiple myeloma suggests that careful hematological follow-up is mandatory. This series expands the spectrum of renal disease in MGRS.
Assuntos
Glomerulonefrite por IGA/imunologia , Glomerulonefrite/imunologia , Doença das Cadeias Pesadas/imunologia , Imunoglobulina A/análise , Rim/imunologia , Mieloma Múltiplo/imunologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Biomarcadores/análise , Biópsia , Proliferação de Células , Diagnóstico Diferencial , Progressão da Doença , Feminino , Imunofluorescência , França , Glomerulonefrite/tratamento farmacológico , Glomerulonefrite/patologia , Glomerulonefrite por IGA/tratamento farmacológico , Glomerulonefrite por IGA/patologia , Doença das Cadeias Pesadas/tratamento farmacológico , Doença das Cadeias Pesadas/patologia , Humanos , Cadeias alfa de Imunoglobulina/análise , Cadeias gama de Imunoglobulina/análise , Rim/efeitos dos fármacos , Rim/ultraestrutura , Masculino , Pessoa de Meia-Idade , Mieloma Múltiplo/tratamento farmacológico , Mieloma Múltiplo/patologia , Valor Preditivo dos Testes , Prognóstico , Estudos Retrospectivos , Fatores de TempoRESUMO
Vulvar Paget's disease is sub-classified into three types based upon its origin. It might be a primary vulvar disease (type 1) or associated with a non-cutaneous adenocarcinoma-rectal, colonic, cervical (type 2) or linked with an urothelial neoplasia (type 3). Type 1lesions must be considered as potentially invasive. Their immunophenotype is CK7+/CK20-. Classically, in case of depth of invasion below 1mm, nodal metastases are exceptional. We report a case of type 1 Paget's disease in a postmenopausal woman with superficial invasion and multiple inguinal nodal metastases.
Assuntos
Metástase Linfática , Doença de Paget Extramamária/patologia , Neoplasias Vulvares/patologia , Idoso , Biomarcadores Tumorais/análise , Feminino , Lobo Frontal , Humanos , Queratinas/análise , Neoplasias Meníngeas , Meningioma , Invasividade Neoplásica , Segunda Neoplasia Primária , Doença de Paget Extramamária/química , Doença de Paget Extramamária/secundário , Peptidil Dipeptidase A/análise , Pós-Menopausa , Receptor ErbB-2/análise , Receptores de Estrogênio/análise , Neoplasias Vulvares/químicaRESUMO
Adenoid cystic carcinoma generally arises from the salivary glands and is rarely found in the female genital tract. Infection with HPV is implicated in this cervical lesion. Differential diagnosis includes adenoid basal carcinoma, polymorphous low-grade adenocarcinoma and basaloid squamous cell carcinoma. Only one case of vaginal localisation was previously described. We report a case of adenoid cystic carcinoma in a 48-year-old woman with previous cervical HPV infection. Histological examination revealed nests of cells with peripheral palisading organisation and glandular lumina containing material produced by the tumor cells.
Assuntos
Carcinoma Adenoide Cístico/patologia , Neoplasias Vaginais/patologia , Actinas/análise , Células Epiteliais/patologia , Feminino , Humanos , Pessoa de Meia-Idade , Infecções por Papillomavirus/patologiaRESUMO
The occurrence of mural nodules in serous or mucinous ovarian tumors is not frequent but is currently well established. Mural nodules can developed in benign, borderline or malignant tumors. They can be reactive, benign or malignant. In these situations, the nodule may be carcinomatous, sarcomatous or mixed. Thus, the prognosis of the ovarian tumor can be dramatically modified by the presence of this nodule. About twenty cases of mural nodules of anaplastic carcinoma have been described. We report an additional case of two mural nodules of anaplastic carcinoma associated with bilateral ovarian borderline mucinous tumor. This tumor was synchronous with a renal cell carcinoma. We give details about the classification, the differential diagnoses and prognosis of these nodules.